A detailed history of Newbridge Financial Services Group, Inc. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 8,000 shares of ARDX stock, worth $48,720. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,000
Previous 8,750 8.57%
Holding current value
$48,720
Previous $63,000 6.35%
% of portfolio
0.02%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 11, 2024

SELL
$5.89 - $9.31 $4,417 - $6,982
-750 Reduced 8.57%
8,000 $59,000
Q1 2024

Apr 24, 2024

BUY
$6.05 - $9.74 $52,937 - $85,225
8,750 New
8,750 $63,000
Q2 2023

Jul 21, 2023

BUY
$3.23 - $4.95 $9,690 - $14,850
3,000 Added 75.0%
7,000 $23,000
Q1 2023

Apr 18, 2023

BUY
$2.68 - $4.79 $10,720 - $19,160
4,000 New
4,000 $19,000
Q3 2021

Oct 27, 2021

SELL
$1.27 - $8.17 $127 - $817
-100 Closed
0 $0
Q2 2021

Sep 07, 2021

BUY
$6.55 - $8.98 $655 - $898
100 New
100 $1,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $942M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.